Literature DB >> 24427329

siRNA-mediated silencing of CDK8 inhibits proliferation and growth in breast cancer cells.

Xiao-Yu Li1, Qi-Feng Luo1, Chuan-Kui Wei1, Deng-Feng Li1, Lin Fang1.   

Abstract

UNLABELLED: CDK8 is a cyclin-dependent kinase (CDK) member of the mediator complex that couples transcriptional regulators to the basal transcriptional machinery, and it has been investigated for possible tumor promoting functions. However, it is unclear whether CDK8 is involved in breast tumor cells growth. The aim of this study was to determine whether the suppression of CDK8 by small interfering RNA (siRNA) inhibits the growth of human breast cancer cell.
METHODS: CDK8-siRNA transfection was used to silencing the CDK8 gene in established breast cancer cell line, MDA-MB-231 and MCF-7, successful transfection being confirmed by Real-time PCR and could be shown by Western Blotting. CDK8 deletion caused significant decline in cell proliferation was observed in breast cancer cell lines as investigated by MTS assay, the number and size of the colonies formed were also significantly reduced in the absence of CDK8. Furthermore, transwell test were conducted to explore the migration of breast cancer cells. Moreover CDK8 gene knockdown arrested cell cycle.
RESULTS: CDK8 mRNA expression was reduced after transfection with CDK8-siRNA, and protein expression had a similar trend. Transfection of CDK8-siRNA suppressed breast cancer cells proliferation and migration; meanwhile the cells were arrested at G0/G1 phase.
CONCLUSIONS: CDK8 plays an essential role in breast cancer progression, which might inhibit the proliferation and migration in breast cancer cells.

Entities:  

Keywords:  Breast cancer; CDK8; siRNA

Mesh:

Substances:

Year:  2013        PMID: 24427329      PMCID: PMC3885463     

Source DB:  PubMed          Journal:  Int J Clin Exp Pathol        ISSN: 1936-2625


  14 in total

Review 1.  Preclinical and clinical development of cyclin-dependent kinase modulators.

Authors:  A M Senderowicz; E A Sausville
Journal:  J Natl Cancer Inst       Date:  2000-03-01       Impact factor: 13.506

Review 2.  siRNA: a potential tool for future breast cancer therapy?

Authors:  Gro Leite Størvold; Tone Ikdahl Andersen; Charles M Perou; Eirik Frengen
Journal:  Crit Rev Oncog       Date:  2006-07

3.  CDK8 is a stimulus-specific positive coregulator of p53 target genes.

Authors:  Aaron Joseph Donner; Stephanie Szostek; Jennifer Michelle Hoover; Joaquin Maximiliano Espinosa
Journal:  Mol Cell       Date:  2007-07-06       Impact factor: 17.970

4.  Dicer-2 and R2D2 coordinately bind siRNA to promote assembly of the siRISC complexes.

Authors:  Xiang Liu; Feng Jiang; Savitha Kalidas; Dean Smith; Qinghua Liu
Journal:  RNA       Date:  2006-06-14       Impact factor: 4.942

5.  Cancer statistics, 2012.

Authors:  Rebecca Siegel; Deepa Naishadham; Ahmedin Jemal
Journal:  CA Cancer J Clin       Date:  2012-01-04       Impact factor: 508.702

Review 6.  Inhibitors of cyclin dependent kinases: useful targets for cancer treatment.

Authors:  P Sapra Sharma; R Sharma; R Tyagi
Journal:  Curr Cancer Drug Targets       Date:  2008-02       Impact factor: 3.428

Review 7.  Calcium and vitamin D supplementation and loss of bone mineral density in women undergoing breast cancer therapy.

Authors:  Mridul Datta; Gary G Schwartz
Journal:  Crit Rev Oncol Hematol       Date:  2013-08-07       Impact factor: 6.312

8.  CDK8 expression in 470 colorectal cancers in relation to beta-catenin activation, other molecular alterations and patient survival.

Authors:  Ron Firestein; Kaori Shima; Katsuhiko Nosho; Natsumi Irahara; Yoshifumi Baba; Emeric Bojarski; Edward L Giovannucci; William C Hahn; Charles S Fuchs; Shuji Ogino
Journal:  Int J Cancer       Date:  2010-06-15       Impact factor: 7.396

9.  Mastermind recruits CycC:CDK8 to phosphorylate the Notch ICD and coordinate activation with turnover.

Authors:  Christy J Fryer; J Brandon White; Katherine A Jones
Journal:  Mol Cell       Date:  2004-11-19       Impact factor: 17.970

Review 10.  Chemopreventive activity of vitamin E in breast cancer: a focus on γ- and δ-tocopherol.

Authors:  Amanda K Smolarek; Nanjoo Suh
Journal:  Nutrients       Date:  2011-11-14       Impact factor: 5.717

View more
  16 in total

1.  STAT1-S727 - the license to kill.

Authors:  Eva M Putz; Dagmar Gotthardt; Veronika Sexl
Journal:  Oncoimmunology       Date:  2014-12-13       Impact factor: 8.110

2.  Silencing of DUSP6 gene by RNAi-mediation inhibits proliferation and growth in MDA-MB-231 breast cancer cells: an in vitro study.

Authors:  Hongming Song; Chenyang Wu; Chuankui Wei; Dengfeng Li; Kaiyao Hua; Jialu Song; Hui Xu; Lei Chen; Lin Fang
Journal:  Int J Clin Exp Med       Date:  2015-07-15

3.  Aberrant expression of CDK8 regulates the malignant phenotype and associated with poor prognosis in human laryngeal squamous cell carcinoma.

Authors:  MingHua Li; XiaoDan Zhao; Ying Liu; Jun An; Hui Xiao; Chao Wang
Journal:  Eur Arch Otorhinolaryngol       Date:  2017-02-20       Impact factor: 2.503

Review 4.  New targeted therapies for breast cancer: A focus on tumor microenvironmental signals and chemoresistant breast cancers.

Authors:  Armel Hervé Nwabo Kamdje; Paul Faustin Seke Etet; Lorella Vecchio; Richard Simo Tagne; Jeremie Mbo Amvene; Jean-Marc Muller; Mauro Krampera; Kiven Erique Lukong
Journal:  World J Clin Cases       Date:  2014-12-16       Impact factor: 1.337

5.  Cyclin-Dependent Kinase Inhibitors as Anticancer Therapeutics.

Authors:  Mary E Law; Patrick E Corsino; Satya Narayan; Brian K Law
Journal:  Mol Pharmacol       Date:  2015-05-27       Impact factor: 4.436

Review 6.  Cyclins and cyclin-dependent kinases: from biology to tumorigenesis and therapeutic opportunities.

Authors:  Mitra Zabihi; Ramin Lotfi; Amir-Mohammad Yousefi; Davood Bashash
Journal:  J Cancer Res Clin Oncol       Date:  2022-07-04       Impact factor: 4.553

7.  Frequent genetic defects in the p16/INK4A tumor suppressor in canine cell models of breast cancer and melanoma.

Authors:  Farruk M Lutful Kabir; Patricia DeInnocentes; Allison Church Bird; R Curtis Bird
Journal:  In Vitro Cell Dev Biol Anim       Date:  2021-05-20       Impact factor: 2.416

Review 8.  Targeting cyclin-dependent kinases in human cancers: from small molecules to Peptide inhibitors.

Authors:  Marion Peyressatre; Camille Prével; Morgan Pellerano; May C Morris
Journal:  Cancers (Basel)       Date:  2015-01-23       Impact factor: 6.639

9.  Analysis of Candida albicans mutants defective in the Cdk8 module of mediator reveal links between metabolism and biofilm formation.

Authors:  Allia K Lindsay; Diana K Morales; Zhongle Liu; Nora Grahl; Anda Zhang; Sven D Willger; Lawrence C Myers; Deborah A Hogan
Journal:  PLoS Genet       Date:  2014-10-02       Impact factor: 5.917

Review 10.  Targeting NK Cells for Anticancer Immunotherapy: Clinical and Preclinical Approaches.

Authors:  Sebastian Carotta
Journal:  Front Immunol       Date:  2016-04-21       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.